The current NRSN market cap is 20.25M. The company's latest EPS is USD -0.5794 and P/E is -0.90.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.24M | -2.89M | -5.59M | -13.55M | -13.3M |
Net Income | -1.22M | -2.83M | -4.04M | -12.34M | -11.28M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 955k | 779k | 11.43M | 7.71M | 3.18M |
Total Liabilities | 37k | 120k | 2.43M | 2.09M | 5.05M |
Total Equity | 918k | 659k | 9.01M | 5.62M | -1.87M |
Market Cap | 20.25M |
Price to Earnings Ratio | -0.90 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 3.83 |
Price to Book Ratio | -5.4 |
Dividend Yield | - |
Shares Outstanding | 19.47M |
Average Volume (1 week) | 112.13k |
Average Volume (1 Month) | 483.65k |
52 Week Change | 26.98% |
52 Week High | 2.33 |
52 Week Low | 0.512 |
Spread (Intraday) | 0.1 (8.77%) |
Company Name | NeuroSense Therapeutics Ltd |
Address |
medinat ha-yehudim street, 85 herzliya, center |
Website | https://www.neurosense-tx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions